Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 184

1.

Rupatadine oral solution for 2-5-year-old children with allergic rhinitis: a safety, open-label, prospective study.

Santamaría E, Izquierdo I, Valle M, Vermeulen J, Potter P.

J Asthma Allergy. 2018 Sep 4;11:225-231. doi: 10.2147/JAA.S164632. eCollection 2018.

2.

Characteristics of patients with severe, uncontrolled, eosinophilic asthma enrolled in a French cohort.

Aubier M, Thabut G, Fabry-Vendrand C.

J Asthma Allergy. 2018 Aug 31;11:217-224. doi: 10.2147/JAA.S170866. eCollection 2018.

3.

School-based supervised therapy programs to improve asthma outcomes: current perspectives.

Salazar G, Tarwala G, Reznik M.

J Asthma Allergy. 2018 Aug 29;11:205-215. doi: 10.2147/JAA.S147524. eCollection 2018. Review.

4.

Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study.

Price DB, Trudo F, Voorham J, Xu X, Kerkhof M, Ling Zhi Jie J, Tran TN.

J Asthma Allergy. 2018 Aug 29;11:193-204. doi: 10.2147/JAA.S176026. eCollection 2018.

5.

Prevalence of allergic sensitization, hay fever, eczema, and asthma in a longitudinal birth cohort.

Owens L, Laing IA, Zhang G, Turner S, Le Souëf PN.

J Asthma Allergy. 2018 Aug 13;11:173-180. doi: 10.2147/JAA.S170285. eCollection 2018.

6.

A purinergic P2Y6 receptor agonist prodrug modulates airway inflammation, remodeling, and hyperreactivity in a mouse model of asthma.

Chetty A, Sharda A, Warburton R, Weinberg EO, Dong J, Fang M, Sahagian GG, Chen T, Xue C, Castellot JJ, Haydon PG, Nielsen HC.

J Asthma Allergy. 2018 Aug 1;11:159-171. doi: 10.2147/JAA.S151849. eCollection 2018.

7.

Economic considerations in the treatment of systemic allergic reactions.

Westermann-Clark E, Pepper AN, Lockey RF.

J Asthma Allergy. 2018 Jun 20;11:153-158. doi: 10.2147/JAA.S159851. eCollection 2018. Review.

8.

Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities.

Prince BT, Mikhail I, Stukus DR.

J Asthma Allergy. 2018 Jun 20;11:143-151. doi: 10.2147/JAA.S159400. eCollection 2018. Review.

9.

Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.

Jimenez-Rodriguez TW, Garcia-Neuer M, Alenazy LA, Castells M.

J Asthma Allergy. 2018 Jun 20;11:121-142. doi: 10.2147/JAA.S159411. eCollection 2018. Review.

10.

Food allergy and anaphylaxis.

Yue D, Ciccolini A, Avilla E, Waserman S.

J Asthma Allergy. 2018 Jun 20;11:111-120. doi: 10.2147/JAA.S162456. eCollection 2018. Review.

11.

Anaphylaxis: getting to the point (and price) of diagnosis and treatment.

Moss RB.

J Asthma Allergy. 2018 Jun 20;11:109-110. doi: 10.2147/JAA.S170650. eCollection 2018. No abstract available.

12.

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.

Ashkenazi M, Sity S, Sarouk I, Bar Aluma BE, Dagan A, Bezalel Y, Bentur L, De Boeck K, Efrati O.

J Asthma Allergy. 2018 Jun 19;11:101-107. doi: 10.2147/JAA.S156049. eCollection 2018.

13.

Methacholine challenge testing: comparative pharmacology.

Davis BE, Blais CM, Cockcroft DW.

J Asthma Allergy. 2018 May 14;11:89-99. doi: 10.2147/JAA.S160607. eCollection 2018. Review.

14.

Acute effects of smoke exposure on airway and systemic inflammation in forest firefighters.

Gianniou N, Giannakopoulou C, Dima E, Kardara M, Katsaounou P, Tsakatikas A, Roussos C, Koulouris N, Rovina N.

J Asthma Allergy. 2018 Apr 23;11:81-88. doi: 10.2147/JAA.S136417. eCollection 2018.

15.

Both fractional exhaled nitric oxide and sputum eosinophil were associated with uncontrolled asthma.

Gao J, Chen Z, Jie X, Ye R, Wu F.

J Asthma Allergy. 2018 Apr 10;11:73-79. doi: 10.2147/JAA.S155379. eCollection 2018.

16.

Assessment of an accessorized pre-filled syringe for home-administered benralizumab in severe asthma.

Ferguson GT, Mansur AH, Jacobs JS, Hebert J, Clawson C, Tao W, Wu Y, Goldman M.

J Asthma Allergy. 2018 Apr 5;11:63-72. doi: 10.2147/JAA.S157762. eCollection 2018.

17.

Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history.

Tabatabaian F, Ledford DK.

J Asthma Allergy. 2018 Apr 3;11:53-61. doi: 10.2147/JAA.S107982. eCollection 2018. Review.

18.

Current perspectives on tree nut allergy: a review.

Weinberger T, Sicherer S.

J Asthma Allergy. 2018 Mar 26;11:41-51. doi: 10.2147/JAA.S141636. eCollection 2018. Review.

19.

Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis.

Cavet ME, Gomes PJ, Carr WW, Williams JI.

J Asthma Allergy. 2018 Mar 23;11:29-39. doi: 10.2147/JAA.S160687. eCollection 2018.

20.

Late-onset asthma: current perspectives.

Hirano T, Matsunaga K.

J Asthma Allergy. 2018 Feb 9;11:19-27. doi: 10.2147/JAA.S125948. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center